OUR MEDICINES

Our product portfolio consists of 16 prescription medicines, all for the treatment of human immunodeficiency virus (HIV). These medicines may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries.

Please note that we are unable to provide detailed information about prescription medicines on this website in compliance with U.K. regulations. You can find local information by selecting your country of residence in the drop-down menu below which will take you to your country specific website if available.

Our global medicines portfolio:

Trademark International non-proprietary name
Vocabria cabotegravir
Rukobia fostemsavir
Cabenuva 
cabotegravir/rilpivirine
Dovato dolutegravir/lamivudine
Juluca
dolutegravir/rilpivirine
Triumeq
dolutegravir/abacavir/lamivudine
Tivicay
dolutegravir
Selzentry/ Celsentri
maraviroc
Epzicom/ Kivexa
abacavir/lamivudine
Ziagen
abacavir
Trizivir
abacavir/lamivudine/zidovudine
Combivir
lamivudine/zidovudine
Epivir
lamivudine
Retrovir
zidovudine
Lexiva/ Telzir
fosamprenavir
Viracept
nelfinavir

Our stories

Date of preparation: August 2021